Month: March 2023

Marker Therapeutics Reports Fiscal Year 2022 Corporate and Financial Results

Written by Customer Service on March 22, 2023. Posted in Earnings Releases And Operating Results.

2022 CLINICAL AND REGULATORY HIGHLIGHTSAwarded $2 million grant from U.S. Food and Drug Administration (FDA) for the Phase 2 ARTEMIS trial of MT-401 in post-transplant acute myeloid leukemia (AML) Investigational New Drug (IND) application cleared by FDA for multicenter Phase 1 trial of MT-601 for the treatment of metastatic pancreatic cancer in combination with front-line chemotherapyReceived FDA Orphan Drug Designation for MT-601 for the treatment of pancreatic cancerIND for MT-601 for the treatment of non-Hodgkin lymphoma cleared by FDA, focused on patients who have failed or are ineligible for CAR-T therapy2022 CORPORATE AND FINANCIAL HIGHLIGHTSEntered into a services agreement with Wilson Wolf Manufacturing Corporation, which included an $8.0 million upfront cash payment from Wilson Wolf Entered into a common stock purchase...

Ollie’s Bargain Outlet Holdings, Inc. Reports Fourth Quarter and Fiscal 2022 Financial Results

Written by Customer Service on March 22, 2023. Posted in Earnings Releases And Operating Results.

~ Q4 Net Sales increased 9.7%; Q4 Comparable Store Sales increased 3.0% ~ ~ Q4 Earnings per Share increased 19.7% to $0.85 ~ ~ Q4 Adjusted Earnings per Share increased 21.7% to $0.84 ~ ~ Initiates Fiscal 2023 Guidance ~ HARRISBURG, Pa., March 22, 2023 (GLOBE NEWSWIRE) — Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) today reported financial results for the fourth quarter and full-year fiscal 2022. Fourth Quarter Summary: Total net sales increased 9.7% to $549.8 million. Comparable store sales increased 3.0% from the prior year decrease of 10.5%. The Company opened 5 new stores, ending the quarter with 468 stores in 29 states, a year-over-year increase in store count of 8.6%. Operating income increased 17.8% to $67.7 million. Adjusted operating income(1) increased 16.5% to $66.8 million and adjusted...

Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Written by Customer Service on March 22, 2023. Posted in Earnings Releases And Operating Results.

Achieved clinical validation of PRISM platform in 2022 – demonstrated ability to potently and durably engage RNA targets and translate preclinical data to the clinic Extended leadership in RNA editing and advanced WVE-006 for AATD – first-in-class RNA editing candidate transitioning to clinical development in 2023 Initiating Part B of WVE-N531 study in exon 53-amenable DMD to assess dystrophin after 24 and 48 weeks of biweekly dosing Strategic collaboration with GSK underway, expected to add multiple first-in-class discovery programs to Wave pipeline, including RNA editing and RNAi programs, as well as potential for up to $3.3 billion in milestone payments Well-capitalized with cash runway into 2025 to deliver on multiple catalysts Wave to host investor conference call and webcast at 8:30 a.m. ET today CAMBRIDGE, Mass., March...

Pieridae Releases Q4 and Full Year 2022 Results, 2022 Reserves & Revises 2023 Guidance

Written by Customer Service on March 22, 2023. Posted in Earnings Releases And Operating Results.

Record Annual Cash Flow & Reserve Value Increase NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES ORDISSEMINATION IN UNITED STATES CALGARY, Alberta, March 22, 2023 (GLOBE NEWSWIRE) — Pieridae Energy Limited (“Pieridae” or the “Company”) (PEA.TO) announces the release of its fourth quarter and full year 2022 financial and operating results and year end 2022 reserves. Pieridae generated Net Operating Income (“NOI”)1 of $201 million and made term debt principal repayments totalling $48 million during 2022. In addition, the Company filed its Annual Information Form (“AIF”) for the year ended December 31, 2022 containing Pieridae’s 2022 independent oil and natural reserves evaluation as required under National Instrument 51-101 Standards of Disclosure of Oil and Gas Activities (“NI51-101”). Pieridae’s...

InflaRx Reports Full Year 2022 Financial and Operating Results

Written by Customer Service on March 22, 2023. Posted in Earnings Releases And Operating Results.

Major progress in development of vilobelimabPhase III study in PG announced following detailed feedback and recommendations from the U.S. Food and Drug Administration (FDA); clinical trial protocol submitted; first patient expected around mid-2023 Fast Track and Orphan Drug designations granted for treatment of pyoderma gangrenosum (PG) in the United States and Orphan Drug designation granted in Europe Encouraging results from Phase III study in critically ill COVID-19 patients published in The Lancet Respiratory Medicine Emergency Use Authorization (EUA) application for treatment of critically ill, invasively mechanically ventilated COVID-19 patients submitted to the FDA; review ongoingFirst-in-human clinical trial with oral C5aR inhibitor INF904 initiated in November 2022; first data expected in H2 2023 Amendment of co-development...

Winnebago Industries Reports Second Quarter Fiscal 2023 Results

Written by Customer Service on March 22, 2023. Posted in Earnings Releases And Operating Results.

— Continued Growth in Marine, with Revenues Up 16% — — Sustained Double-Digit Margins Across All Segments — — Diversified Outdoor Portfolio Continues to Support Profitability and Resiliency — EDEN PRAIRIE, Minn., March 22, 2023 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor lifestyle product manufacturer, today reported financial results for the Company’s Fiscal 2023 second quarter. Second Quarter Fiscal 2023 ResultsRevenues for the Fiscal 2023 second quarter ended February 25, 2023, were $866.7 million, a decrease of 25.6% compared to $1.2 billion for the Fiscal 2022 period, driven by unit volume decreases versus record year-ago comparisons, partially offset by carryover price increases in all segments. Gross profit was $146.8 million, a decrease of 32.2%...

BurgerFi Reports Fourth Quarter and Fiscal Year 2022 Results

Written by Customer Service on March 22, 2023. Posted in Earnings Releases And Operating Results.

Revenue Grows 160% to $178.7 Million in Fiscal Year 2022 Reiterates 2023 Guidance Conference Call today, March 22, at 8:30 a.m. ET FORT LAUDERDALE, Fla., March 22, 2023 (GLOBE NEWSWIRE) — BurgerFi International, Inc. (Nasdaq: BFI, BFIIW) (“BurgerFi” or the “Company”), owner of one of the nation’s leading fast-casual “better burger” dining concepts through the BurgerFi brand, and the high-quality, casual dining pizza brand under the name Anthony’s Coal Fired Pizza & Wings (“Anthony’s”), today reported financial results for the fourth quarter and fiscal year ended January 2, 2023. Highlights for the Fourth Quarter 20221Total revenue increased 29% to $45.2 million in the fourth quarter 2022 compared to $35.1 million in the fourth quarter 2021Consolidated systemwide sales decreased by 2% to $71.6 million. Corporate restaurant...

Baozun Announces Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results

Written by Customer Service on March 22, 2023. Posted in Earnings Releases And Operating Results.

SHANGHAI, China, March 22, 2023 (GLOBE NEWSWIRE) — Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) (“Baozun”, the “Company” or the “Group”), a leading brand e-commerce solution provider and digital commerce enabler in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2022. Fourth Quarter 2022 Financial HighlightsTotal net revenues were RMB2,553.2 million (US$1 370.2 million), a decrease of 19.5% year-over-year, of which, service revenues were RMB1,780.8 million (US$258.2 million), a decrease of 8.3% year-over-year. Income from operations was RMB124.1 million (US$18.0 million), compared with RMB4.0 million in the same quarter of last year. Operating margin was 4.9%, compared with 0.1% for the same period of 2021. Non-GAAP income from operations2 was RMB182.6 million (US$26.5...

Leiðrétting: Nova Klúbburinn hf.: Aðalfundur 29. mars 2023 – Endanleg dagskrá og tillögur

Written by Customer Service on March 22, 2023. Posted in Public Companies.

Aðalfundur Nova Klúbbsins hf. verður haldinn rafrænt og á skrifstofu félagsins að Lágmúla 9, Reykjavík, miðvikudaginn 29. mars 2023, kl. 16:00. Meðfylgjandi er endanleg dagskrá fundarins og tillögur stjórnar, sem er óbreytt frá fundarboðun. Hluthafar eða umboðsmenn hluthafa sem hafa hug á að sækja fundinn, hvort sem er rafrænt eða á staðnum, þurfa að skrá sig á https://www.lumiconnect.com/meeting/nova2023 fyrir kl.16:00 þann 28. mars, eða degi fyrir fundardag. Skráningu á fundinn þarf að fylgja afrit af skilríkjum og umboð, ef við á. Meðfylgjandi eru leiðbeiningar fyrir skráningu og þátttöku á fundinum. Framboðsfrestur vegna framboða til setu í stjórn og tilnefningarnefnd félagsins rennur út kl. 16:00, föstudaginn 24. mars. Fundargögn og allar nánari upplýsingar um fundinn má finna á vefsíðu félagsins, www.nova.is/fjarfestar.Attachments...

Teekay Corporation Completes $30 Million Share Repurchase Program and Announces New Share Repurchase Program

Written by Customer Service on March 22, 2023. Posted in Public Companies.

HAMILTON, Bermuda, March 22, 2023 (GLOBE NEWSWIRE) — Teekay Corporation (Teekay or the Company) (NYSE:TK) today announced that the Company has completed its previously-announced $30 million share repurchase program. Under the program, the Company has repurchased 6.45 million common shares, or approximately 6.3% of the outstanding common shares immediately prior to commencement of the program in August 2022, for a total of $30 million, which equates to an average price of $4.64 per share. In addition, the Company’s Board of Directors has authorized a new share repurchase program for the repurchase of up to $30 million of the Company’s outstanding common shares. Under the program, repurchases can be made from time to time in the open market, through privately-negotiated transactions and by any other means permitted under the rules...

Month: March 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals